8RUU
Fabs derived from bimekizumab in complex with IL-17F
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I03 |
| Synchrotron site | Diamond |
| Beamline | I03 |
| Temperature [K] | 193 |
| Detector technology | PIXEL |
| Collection date | 2014-11-28 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.976 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 99.150, 141.750, 145.560 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 81.950 - 2.810 |
| R-factor | 0.206 |
| Rwork | 0.204 |
| R-free | 0.24150 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1jpy |
| RMSD bond length | 0.007 |
| RMSD bond angle | 1.019 |
| Data reduction software | XDS |
| Data scaling software | xia2 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.18.2_3874) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 81.950 | 2.880 |
| High resolution limit [Å] | 2.810 | 2.810 |
| Rmerge | 0.048 | 0.580 |
| Rmeas | 0.056 | 0.680 |
| Rpim | 0.022 | 0.258 |
| Number of reflections | 50718 | 25323 |
| <I/σ(I)> | 23.2 | 2.9 |
| Completeness [%] | 99.9 | 99.9 |
| Redundancy | 6.5 | 6.8 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 292 | PEG 8000, lithium sulphate, glycerol |






